Publisher
Springer Berlin Heidelberg
Reference28 articles.
1. Arndt R, Dürkopf H, Huland H, Donn F, Loening T, Kalthoff H (1987) Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol 137: 758–763
2. Bander NH (1987) Monoclonal antibodies: State of art. J Urol 137: 603–612
3. Chicheportiche C, Gazarossian E, Longin, A, Lebreuil G, Hermanowicz M, Richaud C, Beley S, Kaphan S, Fontaniére B, Cotte G, Laurent J-C (1993) Combination of standard cytology and immuncytology with BL2–10D1 monoclonal antibody for monitoring-treated bladder cancer patients. Eur Urol 23: 405–408
4. Chopin DK, deKernion JB, Rosenthal DL, Fahey JL (1985) Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 134: 260–265
5. Cordon-Cardo C, Reuter VE, Lloyd KO, Sheinfeld J, Fair WR, Old LJ, Melamed MR (1988) Blood group-related antigens in human urothelium: enhanced expression of precursor, Lex and Ley determinants in urothelial carcinoma. Cancer Res 48: 4113–4118